William L. Carling;Jose L. Martos;Jenny W. Wang;David F. Woodward;Jussi J. Kangasmesta
发明人:
William L. Carling,Jose L. Martos,David F. Woodward,Jenny W. Wang,Jussi J. Kangasmesta
申请号：
US13170467
公开号：
US20120165382A1
申请日:
2011.06.28
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides a compound, that is a 1-[(2-{[(alkyl or aryl)methyl]oxy}halo or haloalkyl substituted-phenyl)alkyl]-5-hydrocarbyl or substituted hydrocarbyl-1H-pyrazole carboxylic acid or alkylenylcarboxylic acid or a hydrocarbyl or substituted hydrocarbyl sulfonamide of said carboxylic acid or said alkylenylcarboxylic acid, provided however said compound is not a 3-carboxylic acid, a sulfonamide thereof, or a 3-methylenylcarboxylic acid. The compound may be represented by the following formulaWherein R1, R2, R3, R4, R5, R6, X, W, X and Y are as defined in the specification. The compounds may be administered to treat DP1, FP, EP1, TP and/or EP4 receptor mediated diseases or conditions.
